Seraxis

Seraxis is a private biotechnology company established in March 2013. Registered in Singapore and the United States, the company’s GMP laboratory is located in Germantown, Maryland. The team of scientists at Seraxis has developed new cell and encapsulation technologies. The company's primary goal is to introduce practical cell therapies for insulin-dependent diabetes into clinical settings, providing long-term treatment options for patients without the need for immunosuppression.